For example, EGFR mutations in glioblastoma are mostly in the extracellular domain and stabilize the open conformation of the receptor to stimulate its autophosphorylation, whereas EGFR mutations in lung adenocarcinoma are often in the tyrosine kinase domain and act to increase the enzymatic activity [68]. Here, EGFR is linked to lung adenocarcinoma.